NCT01410045

Brief Summary

Ovarian insufficiency is common in Turner syndrome related to premature and rapid follicular apoptosis and spontaneous pregnancies are rare in this population. Ovarian cryopreservation has been used in an effort to preserve fertility in patients undergoing treatments which lead to premature and severe ovarian insufficiency. This study aims to assess the relevance of ovarian tissue cryopreservation in girls with Turner syndrome. Based on ovarian follicular density as primary outcome and karyotypic, clinical and hormonal markers as secondary outcomes, analysis of the study will allow to select the patients to whom the procedure would benefit the most.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
47

participants targeted

Target at P25-P50 for not_applicable

Timeline
58mo left

Started Jan 2011

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress76%
Jan 2011Feb 2031

Study Start

First participant enrolled

January 1, 2011

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

June 28, 2011

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 4, 2011

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 16, 2014

Completed
17.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2031

Expected
Last Updated

March 30, 2026

Status Verified

March 1, 2026

Enrollment Period

3 years

First QC Date

June 28, 2011

Last Update Submit

March 25, 2026

Conditions

Keywords

Turner syndromeinfertilityovarian insufficiencyovarian cryopreservation

Outcome Measures

Primary Outcomes (1)

  • the ovarian follicular density

    the specific measure is the ovarian follicular density which will allow to Identify criteria, to predict existence or absence of ovarian follicles at the time of the surgery

    at the time of the ovariectomy

Secondary Outcomes (1)

  • measure hormonal markers

    Before the ovariectomy, 1 month and 12 months after the ovariectomy

Study Arms (1)

Surgery

EXPERIMENTAL

Ovariectomy

Procedure: Ovariectomy

Interventions

OvariectomyPROCEDURE

Ovarian cryopreservation has been used in an effort to preserve fertility in patients undergoing treatments which lead to premature and severe ovarian insufficiency.

Surgery

Eligibility Criteria

Age1 Year - 25 Years
Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • girls aged from 1 to 25 years included,
  • with Turner syndrome or mosaic
  • patients aged more than 18 will only have ovarian insufficiency dated less than 5 years
  • without any severe disease, particularly of cardiovascular type
  • whose agreement to participate to the study has been signed by the parents
  • whose agreement to participate to the study has been signed by majority age patient

You may not qualify if:

  • girls aged less than one year and over 25 years old
  • if any surgery would be contra-indicated
  • ovary alone presence
  • Well-known infection by HIV, and/or HBV, and/or HCV and/or syphilis TPHA VDRL
  • No social coverage affiliate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hopital Bicêtre

Le Kremlin-Bicêtre, 94275, France

Location

MeSH Terms

Conditions

Turner SyndromeInfertility

Interventions

Ovariectomy

Condition Hierarchy (Ancestors)

Gonadal DysgenesisDisorders of Sex DevelopmentUrogenital AbnormalitiesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesSex Chromosome Disorders of Sex DevelopmentMale Urogenital DiseasesHeart Defects, CongenitalCardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesSex Chromosome DisordersChromosome DisordersGenetic Diseases, InbornGonadal DisordersEndocrine System DiseasesGenital Diseases

Intervention Hierarchy (Ancestors)

CastrationEndocrine Surgical ProceduresSurgical Procedures, OperativeUrogenital Surgical ProceduresGynecologic Surgical Procedures

Study Officials

  • Lise Duranteau, MD, PhD

    Assistance Publique - Hôpitaux de Paris

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 28, 2011

First Posted

August 4, 2011

Study Start

January 1, 2011

Primary Completion

January 16, 2014

Study Completion (Estimated)

February 1, 2031

Last Updated

March 30, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations